Related references
Note: Only part of the references are listed.PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B
Patrick Marcellin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
High Liver Fibrosis Index FIB-4 Is Highly Predictive of Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Beomseok Suh et al.
HEPATOLOGY (2015)
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends et al.
GUT (2015)
Comparison of Diagnostic Accuracy of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Adult Patients With Chronic Hepatitis B Virus Infection: A Systemic Review and Meta-analysis
Guangqin Xiao et al.
HEPATOLOGY (2015)
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
JOURNAL OF HEPATOLOGY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-termclinical outcome in chronic hepatitis B patients
Willem P. Brouwer et al.
LIVER INTERNATIONAL (2015)
Net Reclassification Improvement: Computation, Interpretation, and Controversies
Maarten J. G. Leening et al.
ANNALS OF INTERNAL MEDICINE (2014)
Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus
V. de Ledinghen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
Tai-Chung Tseng et al.
HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2011)
Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
Maurizia Rossana Brunetto et al.
GASTROENTEROLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
Man-Fung Yuen et al.
JOURNAL OF HEPATOLOGY (2009)
Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
J. J. Y. Sung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B
W. G. Shin et al.
DIGESTIVE AND LIVER DISEASE (2008)
Liver biopsy assessment in chronic hepatitis
Jay H. Lefkowitch
ARCHIVES OF MEDICAL RESEARCH (2007)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
A novel panel of blood markers to assess the degree of liver fibrosis
P Calès et al.
HEPATOLOGY (2005)
Sources of variability in histological scoring of chronic viral hepatitis
MC Rousselet et al.
HEPATOLOGY (2005)
Current concepts: Liver biopsy.
AA Bravo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
